Condition
Functioanl Dyspepsia
Total Trials
6
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (3)
P 2 (1)
P 4 (2)
Trial Status
Not Yet Recruiting3
Completed2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06630455Not ApplicableCompletedPrimary
Meu-cinn for Gastric Mucosal Health in Adults With Functional Dyspepsia
NCT07731542Not ApplicableRecruitingPrimary
Vonoprazan Alone vs With Itopride for Functional Dyspepsia: The VIVA Trial
NCT07578402Phase 4Not Yet Recruiting
Effect of Digestive Enzymes as Add on Therapy on Patients With Functional Dyspepsia.
NCT07449689Phase 4Not Yet RecruitingPrimary
Comparing Acotiamide and Itopride for the Management of Indigestion
NCT06931223Not ApplicableNot Yet RecruitingPrimary
Efficacy of Gut-Brain Neuromodulators for Functional Dyspepsia
NCT00458328Phase 2CompletedPrimary
The Effect of Z-338 in Subjects With Functional Dyspepsia
Showing all 6 trials